Vaccine plant problems put Sanofi shot supplies in dire straits

Last year, the FDA came down hard on a Sanofi Pasteur plant in Toronto. The ensuing trouble triggered serious supply problems--and, in turn, a shortage of childhood vaccines in the U.S. Sanofi's ($SNY) third-quarter vaccines sales took a big hit from that shortage, and supply won't be back to normal till the first quarter of 2014. Report